APA (7th ed.) Citation

Ascher, B., Hoffmann, K., Walker, P., Lippert, S., Wollina, U., & Havlickova, B. (2014). Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: Results from a phase III, randomized, placebo-controlled study. Journal of the European Academy of Dermatology and Venereology, 28(12), 1707-1715. https://doi.org/10.1111/jdv.12377

Chicago Style (17th ed.) Citation

Ascher, B., K. Hoffmann, P. Walker, S. Lippert, U. Wollina, and B. Havlickova. "Efficacy, Patient-reported Outcomes and Safety Profile of ATX-101 (deoxycholic Acid), an Injectable Drug for the Reduction of Unwanted Submental Fat: Results from a Phase III, Randomized, Placebo-controlled Study." Journal of the European Academy of Dermatology and Venereology 28, no. 12 (2014): 1707-1715. https://doi.org/10.1111/jdv.12377.

MLA (9th ed.) Citation

Ascher, B., et al. "Efficacy, Patient-reported Outcomes and Safety Profile of ATX-101 (deoxycholic Acid), an Injectable Drug for the Reduction of Unwanted Submental Fat: Results from a Phase III, Randomized, Placebo-controlled Study." Journal of the European Academy of Dermatology and Venereology, vol. 28, no. 12, 2014, pp. 1707-1715, https://doi.org/10.1111/jdv.12377.